Giacomo Vezzani

Employment

• GSK Vaccines Institute for Global Health Scientist
  2024 - Present
• GSK Vaccines Institute for Global Health Post Doctoral
  2022 - 2024
• GSK Vaccines SRL PhD Student
  2018 - 2022

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (6)

• Development and characterization of pseudotype-based microneutralization assay to assess functionality of anti-rabies protein G antibodies
  F1000Research 2026 DOI: 10.12688/f1000research.178284.1
  +Save
• Development and Characterization of a 13-Plex Binding Assay to Detect Shigella Antibodies in Human Samples
  Open Forum Infectious Diseases 2024 DOI: 10.1093/ofid/ofae675
  +Save
• Strategies to Tackle Antimicrobial Resistance: The Example of Escherichia coli and Pseudomonas aeruginosa
  International Journal of Molecular Sciences 2021 DOI: 10.3390/ijms22094943
  +Save
• The Human Cytomegalovirus UL116 Glycoprotein Is a Chaperone to Control gH-Based Complexes Levels on Virions.
  Frontiers in microbiology 2021 DOI: 10.3389/fmicb.2021.630121
  +Save
• The human cytomegalovirus UL116 glycoprotein is a chaperone to control gH-based complexes levels on virions
  2020 DOI: 10.1101/2020.11.18.387126
  +Save
• Characterization of pUL5, an HCMV protein interacting with the cellular protein IQGAP1.
  Virology 2019 DOI: 10.1016/j.virol.2019.10.018
  +Save